Clinical Trial Update: A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate the effect of intranasal insulin on postprandial glycemic control in Type 2 diabetes mellitus. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Nasal insulin (insulin)

Snippet

Sponsor: Nastech Pharmaceutical Company, Inc. | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED